Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share
Tweet
Share
E-mailGet Alerts CXM Hot Sheet
Price: $7.38 -0.67%
Financial Fact:
Total operating expenses: 1.19M
Today's EPS Names:
SQZB, ARDS, MDRX, More
Financial Fact:
Total operating expenses: 1.19M
Today's EPS Names:
SQZB, ARDS, MDRX, More
Join SI Premium – FREE
Cardium Therapeutics, Inc. (NYSE: CXM) reported Q1 EPS of ($0.02), versus ($0.02) reported last year.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IMF chief says global economy weathered Iran war shock well
- Raymond James: 'We now believe that 12 of the top 20 pharma companies have selected Veeva CRM'
- Truckload stocks: Seasonal pullback a buying opportunity, says Benchmark
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
